BasePurifier™ 48
Large Volume Nucleic Acid Extraction System
48 rotating rods
The BasePurifier™ 48 Nucleic Acid Extraction Rotating System is used for clinical diagnostics, scientific research, disease control, food safety, forensic medicine, among others. Featuring large sample volume of up to 1mL, automated nucleic acid extraction using rotational mixing and fast extraction speed. The instrument has a through put of up to 48 samples per run.
- Ultra-quiet design
- Large sample volume
- Cross-Contamination control
- Easy to use
Product Details
Reference Number: 718
Product name BasePurifier™ 48 Large Volume Nucleic Acid Extraction System 48 rotating rods
Intended Use
PentaBase’s BasePurifier™ 48 has a large volume extraction solution with a 1 mL sample volume,
which can support extraction from samples with low nucleic acid concentration.
The BasePurifier™ 48 and 96 have stringent contamination control with rotary technology, which
minimizes the risk of cross-contamination.
Product Specifications
Capacity 1 to 48 samples
Reaction Volume 50 – 3000 μL
Recommended Sample Volume 1000 μL
Consumables Customised 48-deep-well plates
Custom rod covers Sleeves
Mixing Method Rotational mixing
Rotation Speed 100-3000 rpm adjustable
Heating Temperature Lysis heating: Room temperature to 120˚C
Elution heating: Room temperature to 120˚C
Disinfection UV-lamp and 70% Ethanol
Program Storage Up to 1000 programs with the built-in modules
Connection Options 7-inch full-color LED touch screen operation
Operating Power and Noise 240V
<80 db(A)
Instrument Dimension and Weight 49 cm (L) x 51 cm (W) x 48 cm (H)
45 kg (net)
Instructions For Use
The latest version of the Instructions For Use can be found at: 5ba.se/PP004 (ændre navnet)
Assisting the Stratification of Lymphomas
The PlentiPlex™ MYD88 L265P assay is intended for in vitro diagnosis of the leucine to proline mutation in codon 265 of the Myeloid differentiation primary response 88 protein (MYD88 L265P) in genomic DNA (gDNA) samples. The obtained results of the PlentiPlex™ MYD88 L265P assay are intended for assisting in the discrimination between patients with Lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia (LPL/WM) and other non-Hodgkin lymphomas.
